306 related articles for article (PubMed ID: 34313755)
1. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.
Press DM; Siperstein AE; Berber E; Shin JJ; Metzger R; Monteiro R; Mino J; Swagel W; Mitchell JC
Surgery; 2013 Dec; 154(6):1232-7; discussion 1237-8. PubMed ID: 24383100
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism.
Silva BC; Cusano NE; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperparathyroidism.
Walker MD; Silverberg SJ
Nat Rev Endocrinol; 2018 Feb; 14(2):115-125. PubMed ID: 28885621
[TBL] [Abstract][Full Text] [Related]
7. Primary Hyperparathyroidism.
Bilezikian JP
J Clin Endocrinol Metab; 2018 Nov; 103(11):3993-4004. PubMed ID: 30060226
[TBL] [Abstract][Full Text] [Related]
8. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
Lin X; Fan Y; Zhang Z; Yue H
Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
[TBL] [Abstract][Full Text] [Related]
10. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
11. Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.
Na D; Tao G; Shu-Ying L; Qin-Yi W; Xiao-Li Q; Yong-Fang L; Yang-Na O; Zhi-Feng S; Yan-Yi Y
BMC Endocr Disord; 2021 Aug; 21(1):170. PubMed ID: 34416890
[TBL] [Abstract][Full Text] [Related]
12. Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism.
Lai V; Yen TW; Doffek K; Carr AA; Carroll TB; Fareau GG; Evans DB; Wang TS
Ann Surg Oncol; 2016 Jul; 23(7):2310-4. PubMed ID: 27006125
[TBL] [Abstract][Full Text] [Related]
13. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones.
Ganesan C; Weia B; Thomas IC; Song S; Velaer K; Seib CD; Conti S; Elliott C; Chertow GM; Kurella Tamura M; Leppert JT; Pao AC
JAMA Surg; 2020 Sep; 155(9):861-868. PubMed ID: 32725208
[TBL] [Abstract][Full Text] [Related]
16. Primary Hyperparathyroidism: Effects on Bone Health.
Zanocco KA; Yeh MW
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):87-104. PubMed ID: 28131138
[TBL] [Abstract][Full Text] [Related]
17. Mild primary hyperparathyroidism: a literature review.
Applewhite MK; Schneider DF
Oncologist; 2014 Sep; 19(9):919-29. PubMed ID: 25063228
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia: A Review.
Walker MD; Shane E
JAMA; 2022 Oct; 328(16):1624-1636. PubMed ID: 36282253
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
Peacock M; Bilezikian JP; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
J Clin Endocrinol Metab; 2011 Jan; 96(1):E9-18. PubMed ID: 20943783
[TBL] [Abstract][Full Text] [Related]
20. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
